FSD Pharma Inc. Class B Subordinate Voting Shares
HUGE
HUGE: FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.
moreShow HUGE Financials
Recent trades of HUGE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HUGE's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HUGE's company Twitter account
Number of mentions of HUGE in WallStreetBets Daily Discussion
Recent insights relating to HUGE
Recent picks made for HUGE stock on CNBC
ETFs with the largest estimated holdings in HUGE
Flights by private jets registered to HUGE